Gap finder

Search review questions

Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.

Limit to evidence status or GRADE (optional)

601 questions in 75 reviews · Schizophrenia

current versions
No studies 601 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

QuestionEffectEvidenceStatus / GRADE
HALOPERIDOL vs COMBINATIONS: a. HALOPERIDOL + LEVOMEPROMAZINE
Adverse effect: any serious, specific ‐ not reported · patients with psychosis‐induced aggression or agitation
Haloperidol for psychosis‐induced aggression or agitation (rapid tranquillisation) (2017) · Cochrane
no estimate extractedNRNo studies
HALOPERIDOL vs COMBINATIONS: a. HALOPERIDOL + LEVOMEPROMAZINE
Economic outcome ‐ not measured · patients with psychosis‐induced aggression or agitation
Haloperidol for psychosis‐induced aggression or agitation (rapid tranquillisation) (2017) · Cochrane
no estimate extractedNRNo studies
HALOPERIDOL vs COMBINATIONS: b. HALOPERIDOL + LORAZEPAM
Specific behaviour ‐ threat or injury to self or others ‐ not reported · patients with psychosis‐induced aggression or agitation
Haloperidol for psychosis‐induced aggression or agitation (rapid tranquillisation) (2017) · Cochrane
no estimate extractedNRNo studies
HALOPERIDOL vs COMBINATIONS: b. HALOPERIDOL + LORAZEPAM
Economic outcome ‐ not reported · patients with psychosis‐induced aggression or agitation
Haloperidol for psychosis‐induced aggression or agitation (rapid tranquillisation) (2017) · Cochrane
no estimate extractedNRNo studies
HALOPERIDOL vs COMBINATIONS: c. HALOPERIDOL + MIDAZOLAM
Tranquillisation or asleep ‐ not reported · psychosis‐induced aggression or agitation
Haloperidol for psychosis‐induced aggression or agitation (rapid tranquillisation) (2017) · Cochrane
no estimate extractedNRNo studies
HALOPERIDOL vs COMBINATIONS: c. HALOPERIDOL + MIDAZOLAM
Economic outcome ‐ not reported · psychosis‐induced aggression or agitation
Haloperidol for psychosis‐induced aggression or agitation (rapid tranquillisation) (2017) · Cochrane
no estimate extractedNRNo studies
HALOPERIDOL vs OTHER ANTIPSYCHOTIC: a. ARIPIPRAZOLE
Economic outcome ‐ not reported · patients with psychosis‐induced aggression or agitation
Haloperidol for psychosis‐induced aggression or agitation (rapid tranquillisation) (2017) · Cochrane
no estimate extractedNRNo studies
HALOPERIDOL vs COMBINATIONS: d. HALOPERIDOL + PROMETHAZINE
Economic outcome ‐ not reported · psychosis‐induced aggression or agitation
Haloperidol for psychosis‐induced aggression or agitation (rapid tranquillisation) (2017) · Cochrane
no estimate extractedNRNo studies
HALOPERIDOL vs COMBINATIONS: e. HALOPERIDOL + RISPERIDONE
Tranquillisation or asleep ‐ not reported · psychosis‐induced aggression or agitation
Haloperidol for psychosis‐induced aggression or agitation (rapid tranquillisation) (2017) · Cochrane
no estimate extractedNRNo studies
HALOPERIDOL vs COMBINATIONS: e. HALOPERIDOL + RISPERIDONE
Repeated need for tranquillisation ‐ not reported · psychosis‐induced aggression or agitation
Haloperidol for psychosis‐induced aggression or agitation (rapid tranquillisation) (2017) · Cochrane
no estimate extractedNRNo studies
HALOPERIDOL vs COMBINATIONS: e. HALOPERIDOL + RISPERIDONE
Economic outcome ‐ not reported · psychosis‐induced aggression or agitation
Haloperidol for psychosis‐induced aggression or agitation (rapid tranquillisation) (2017) · Cochrane
no estimate extractedNRNo studies
HALOPERIDOL vs COMBINATIONS: f. OLANZAPINE + MAGNESIUM VALPROATE
Tranquillisation or asleep ‐ not reported · psychosis‐induced aggression or agitation
Haloperidol for psychosis‐induced aggression or agitation (rapid tranquillisation) (2017) · Cochrane
no estimate extractedNRNo studies
HALOPERIDOL vs COMBINATIONS: f. OLANZAPINE + MAGNESIUM VALPROATE
Repeated need for tranquillisation ‐ not reported · psychosis‐induced aggression or agitation
Haloperidol for psychosis‐induced aggression or agitation (rapid tranquillisation) (2017) · Cochrane
no estimate extractedNRNo studies
HALOPERIDOL vs COMBINATIONS: f. OLANZAPINE + MAGNESIUM VALPROATE
Economic outcome ‐ not reported · psychosis‐induced aggression or agitation
Haloperidol for psychosis‐induced aggression or agitation (rapid tranquillisation) (2017) · Cochrane
no estimate extractedNRNo studies
HALOPERIDOL vs COMBINATIONS: g. QUETIAPINE + MAGNESIUM VALPROATE
Tranquillisation or asleep ‐ not reported · patients with psychosis‐induced aggression or agitation
Haloperidol for psychosis‐induced aggression or agitation (rapid tranquillisation) (2017) · Cochrane
no estimate extractedNRNo studies
HALOPERIDOL vs COMBINATIONS: g. QUETIAPINE + MAGNESIUM VALPROATE
Repeated need for tranquillisation ‐ not reported · patients with psychosis‐induced aggression or agitation
Haloperidol for psychosis‐induced aggression or agitation (rapid tranquillisation) (2017) · Cochrane
no estimate extractedNRNo studies
HALOPERIDOL vs COMBINATIONS: g. QUETIAPINE + MAGNESIUM VALPROATE
Adverse effects ‐ any specific, serious ‐ not reported · patients with psychosis‐induced aggression or agitation
Haloperidol for psychosis‐induced aggression or agitation (rapid tranquillisation) (2017) · Cochrane
no estimate extractedNRNo studies
HALOPERIDOL vs COMBINATIONS: h. RISPERIDONE + CLONAZEPAM
Repeated need for tranquillisation ‐ not reported · psychosis induced aggression or agitation
Haloperidol for psychosis‐induced aggression or agitation (rapid tranquillisation) (2017) · Cochrane
no estimate extractedNRNo studies
HALOPERIDOL vs COMBINATIONS: h. RISPERIDONE + CLONAZEPAM
Economic outcome ‐ not reported · psychosis induced aggression or agitation
Haloperidol for psychosis‐induced aggression or agitation (rapid tranquillisation) (2017) · Cochrane
no estimate extractedNRNo studies
HALOPERIDOL vs COMBINATIONS: i. ZIPRASIDONE + CLONAZEPAM
Tranquillisation or asleep ‐ not reported · psychosis‐induced aggression or agitation
Haloperidol for psychosis‐induced aggression or agitation (rapid tranquillisation) (2017) · Cochrane
no estimate extractedNRNo studies
HALOPERIDOL vs COMBINATIONS: i. ZIPRASIDONE + CLONAZEPAM
Repeated need for tranquillisation ‐ not reported · psychosis‐induced aggression or agitation
Haloperidol for psychosis‐induced aggression or agitation (rapid tranquillisation) (2017) · Cochrane
no estimate extractedNRNo studies
HALOPERIDOL vs OTHER ANTIPSYCHOTIC: b. CHLORPROMAZINE
Specific behaviour ‐ threat or injury of harm to self or others ‐ not reported · patients with psychosis‐induced aggression or agitation
Haloperidol for psychosis‐induced aggression or agitation (rapid tranquillisation) (2017) · Cochrane
no estimate extractedNRNo studies
HALOPERIDOL vs COMBINATIONS: i. ZIPRASIDONE + CLONAZEPAM
Global outcome ‐ no improvement ‐ not reported · psychosis‐induced aggression or agitation
Haloperidol for psychosis‐induced aggression or agitation (rapid tranquillisation) (2017) · Cochrane
no estimate extractedNRNo studies
HALOPERIDOL vs COMBINATIONS: i. ZIPRASIDONE + CLONAZEPAM
Adverse effects ‐ not reported · psychosis‐induced aggression or agitation
Haloperidol for psychosis‐induced aggression or agitation (rapid tranquillisation) (2017) · Cochrane
no estimate extractedNRNo studies
HALOPERIDOL vs COMBINATIONS: i. ZIPRASIDONE + CLONAZEPAM
Economic outcome ‐ not reported · psychosis‐induced aggression or agitation
Haloperidol for psychosis‐induced aggression or agitation (rapid tranquillisation) (2017) · Cochrane
no estimate extractedNRNo studies
HALOPERIDOL vs OTHER ANTIPSYCHOTIC: b. CHLORPROMAZINE
Economic outcome ‐ not reported · patients with psychosis‐induced aggression or agitation
Haloperidol for psychosis‐induced aggression or agitation (rapid tranquillisation) (2017) · Cochrane
no estimate extractedNRNo studies
HALOPERIDOL vs OTHER ANTIPSYCHOTIC: c. DROPERIDOL
Specific behaviour ‐ threat or injury to self or others ‐ not reported · psychosis‐induced aggression or agitation
Haloperidol for psychosis‐induced aggression or agitation (rapid tranquillisation) (2017) · Cochrane
no estimate extractedNRNo studies
HALOPERIDOL vs OTHER ANTIPSYCHOTIC: c. DROPERIDOL
Economic outcome ‐ not reported · psychosis‐induced aggression or agitation
Haloperidol for psychosis‐induced aggression or agitation (rapid tranquillisation) (2017) · Cochrane
no estimate extractedNRNo studies
HALOPERIDOL vs OTHER ANTIPSYCHOTIC: d. LOXAPINE
Economic outcome ‐ not reported · patients to psychosis‐induced aggression or agitation
Haloperidol for psychosis‐induced aggression or agitation (rapid tranquillisation) (2017) · Cochrane
no estimate extractedNRNo studies
HALOPERIDOL vs OTHER ANTIPSYCHOTIC: e. OLANZAPINE
Economic outcome ‐ not reported · psychosis induced aggression or agitation
Haloperidol for psychosis‐induced aggression or agitation (rapid tranquillisation) (2017) · Cochrane
no estimate extractedNRNo studies
HALOPERIDOL vs OTHER ANTIPSYCHOTIC: f. PERPHENAZINE
Tranquillisation or asleep ‐ not reported · patients with psychosis‐induced aggression or agitation
Haloperidol for psychosis‐induced aggression or agitation (rapid tranquillisation) (2017) · Cochrane
no estimate extractedNRNo studies
HALOPERIDOL vs OTHER ANTIPSYCHOTIC: f. PERPHENAZINE
Repeated need for rapid tranquillisation ‐ not reported · patients with psychosis‐induced aggression or agitation
Haloperidol for psychosis‐induced aggression or agitation (rapid tranquillisation) (2017) · Cochrane
no estimate extractedNRNo studies
HALOPERIDOL vs OTHER ANTIPSYCHOTIC: f. PERPHENAZINE
Specific behaviour ‐ injury or threat of self to others ‐ not reported · patients with psychosis‐induced aggression or agitation
Haloperidol for psychosis‐induced aggression or agitation (rapid tranquillisation) (2017) · Cochrane
no estimate extractedNRNo studies
HALOPERIDOL vs OTHER ANTIPSYCHOTIC: f. PERPHENAZINE
Economic outcome ‐ not reported · patients with psychosis‐induced aggression or agitation
Haloperidol for psychosis‐induced aggression or agitation (rapid tranquillisation) (2017) · Cochrane
no estimate extractedNRNo studies
HALOPERIDOL vs OTHER ANTIPSYCHOTICS: g. QUETIAPINE
Tranquillisation or asleep ‐ not reported · psychosis‐induced aggression or agitation
Haloperidol for psychosis‐induced aggression or agitation (rapid tranquillisation) (2017) · Cochrane
no estimate extractedNRNo studies
HALOPERIDOL vs OTHER ANTIPSYCHOTICS: g. QUETIAPINE
Repeated need for tranquillisation ‐ not reported · psychosis‐induced aggression or agitation
Haloperidol for psychosis‐induced aggression or agitation (rapid tranquillisation) (2017) · Cochrane
no estimate extractedNRNo studies
HALOPERIDOL vs OTHER ANTIPSYCHOTICS: g. QUETIAPINE
Global outcome ‐ not reported · psychosis‐induced aggression or agitation
Haloperidol for psychosis‐induced aggression or agitation (rapid tranquillisation) (2017) · Cochrane
no estimate extractedNRNo studies
HALOPERIDOL vs OTHER ANTIPSYCHOTICS: g. QUETIAPINE
Economic outcome ‐ not reported · psychosis‐induced aggression or agitation
Haloperidol for psychosis‐induced aggression or agitation (rapid tranquillisation) (2017) · Cochrane
no estimate extractedNRNo studies
HALOPERIDOL vs OTHER ANTIPSYCHOTIC: h. RISPERIDONE
Economic outcome ‐ not reported · patients with psychosis‐induced aggression or agitation
Haloperidol for psychosis‐induced aggression or agitation (rapid tranquillisation) (2017) · Cochrane
no estimate extractedNRNo studies
HALOPERIDOL vs OTHER ANTIPSYCHOTIC: i. THIOTHIXENE
Tranquillisation or asleep ‐ not reported · patients with psychosis‐induced aggression or agitation
Haloperidol for psychosis‐induced aggression or agitation (rapid tranquillisation) (2017) · Cochrane
no estimate extractedNRNo studies
HALOPERIDOL vs PLACEBO/NIL
Economic outcome ‐ not reported · patients with psychosis‐induced aggression or agitation
Haloperidol for psychosis‐induced aggression or agitation (rapid tranquillisation) (2017) · Cochrane
no estimate extractedNRNo studies
HALOPERIDOL vs OTHER ANTIPSYCHOTIC: i. THIOTHIXENE
Specific behaviour ‐ threat or injury to self or others ‐ not reported · patients with psychosis‐induced aggression or agitation
Haloperidol for psychosis‐induced aggression or agitation (rapid tranquillisation) (2017) · Cochrane
no estimate extractedNRNo studies
HALOPERIDOL vs OTHER ANTIPSYCHOTIC: i. THIOTHIXENE
Economic outcome ‐ not reported · patients with psychosis‐induced aggression or agitation
Haloperidol for psychosis‐induced aggression or agitation (rapid tranquillisation) (2017) · Cochrane
no estimate extractedNRNo studies
HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE
Tranquilisation or asleep ‐ not reported · psychosis‐induced aggression or agitation
Haloperidol for psychosis‐induced aggression or agitation (rapid tranquillisation) (2017) · Cochrane
no estimate extractedNRNo studies
HALOPERIDOL vs OTHER ANTIPSYCHOTIC: a. ARIPIPRAZOLE
Tranquillisation or asleep ‐ not reported · patients with psychosis‐induced aggression or agitation
Haloperidol for psychosis‐induced aggression or agitation (rapid tranquillisation) (2017) · Cochrane
no estimate extractedNRNo studies
HALOPERIDOL vs OTHER ANTIPSYCHOTIC: j. ZIPRASIDONE
Economic outcome ‐ not reported · psychosis‐induced aggression or agitation
Haloperidol for psychosis‐induced aggression or agitation (rapid tranquillisation) (2017) · Cochrane
no estimate extractedNRNo studies
HALOPERIDOL vs OTHER ANTIPSYCHOTIC: k. ZUCLOPENTHIXOL ACETATE
Tranquillisation or asleep ‐ not reported · patients with psychosis‐induced aggression or agitation
Haloperidol for psychosis‐induced aggression or agitation (rapid tranquillisation) (2017) · Cochrane
no estimate extractedNRNo studies
HALOPERIDOL vs OTHER ANTIPSYCHOTIC: k. ZUCLOPENTHIXOL ACETATE
Specific behaviour ‐ threat or injury to self or others ‐ not reported · patients with psychosis‐induced aggression or agitation
Haloperidol for psychosis‐induced aggression or agitation (rapid tranquillisation) (2017) · Cochrane
no estimate extractedNRNo studies
HALOPERIDOL vs OTHER ANTIPSYCHOTIC: k. ZUCLOPENTHIXOL ACETATE
Global outcome ‐ not reported · patients with psychosis‐induced aggression or agitation
Haloperidol for psychosis‐induced aggression or agitation (rapid tranquillisation) (2017) · Cochrane
no estimate extractedNRNo studies
HALOPERIDOL vs OTHER ANTIPSYCHOTIC: k. ZUCLOPENTHIXOL ACETATE
Economic outcome ‐ not reported · patients with psychosis‐induced aggression or agitation
Haloperidol for psychosis‐induced aggression or agitation (rapid tranquillisation) (2017) · Cochrane
no estimate extractedNRNo studies